Document Type : Original Research

Authors

1 Department of Pathology and Laboratory Medicine, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

2 Imam Hossein Central Medical Laboratory, Shahid Beheshti University of Medical Sciences, Tehran, Iran

3 Department of Pathology, Afzalipour Medical School, Kerman, Iran

4 Pathology and Stem Cells Research Center, Kerman Medical School, Kerman University of Medical Sciences, Kerman, Iran

5 Department of Pathology and laboratory medicine, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

6 Department of Radiology, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

7 Department of Pathology, Resident NYU Langone Health, Mineloa, NY, USA

8 Department of Hematology, Iran University of Medical Sciences, Tehran, Iran

Abstract

Background & Objective: Coronavirus disease 2019 (COVID-19) is progressively spreading, and many researchers have focused on the prognostic value of laboratory analyses. This study reviewed routine blood parameters, upper respiratory viral load, and chest imaging in recovered and expired COVID-19 patients and evaluated possible correlations.
Methods: In this retrograde study, 138 COVID-19 cases were enrolled. Chest tomography scores of patients, routine hematologic and  biochemical parameters, and respiratory viral loads were measured. Furthermore, their correlation with severity of disease  and the outcome was investigated during a week of admission.
Results: The mean age of participants was 58.6±16;  36.2% of whom were diagnosed as critical, 8.7% expired, and 46% showed less than 50% lung opacity. The expiring rate was only correlated to the severity of illness and viral load. During admission, hemoglobin concentration was decreased in critical patients (from 11.49±0.27 to 10.59±0.36, P=0.042) and also among CT-scan scoring groups (P=0.000), while neutrophils (P=0.04), WBC (P=0.03), and platelets (P=0.000) count were increased. In patients with more than 50% lung opacity, leukocyte counts were decreased, but neutrophil and platelets counts showed raise (all P<0.05), while other hematologic parameters did not change. CRP and LDH demonstrated no  increase based on the severity of the illness, RT-PCR viral loads and/or outcome. However, both CRP and LDH were increased in patients with more than 50% lobal opacity (CRP: 69.3±9.9 to 1021.1±7.5 and LDH:589.5±93.2 to 1128.6±15.81, P<0.05).
Conclusion: We found that hemoglobin, white blood cells, neutrophil, lymphocytes, and platelets count together with chest tomography score might be beneficial for expedition the  diagnosis, assessmen the severity of the disease, and outcome in the hospitalized cases, while CRP and LDH might be considered as the consequence of lung involvement.

Keywords

Main Subjects

  1. Chan JF, Kok KH, Zhu Z, Chu H, To KK, Yuan S, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020;9(1):221-36. [PMID] [PMCID] [DOI:10.1080/22221751.2020.1719902]
  2. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-33. [PMID] [PMCID] [DOI:10.1056/NEJMoa2001017]
  3. Yavarian J, Shafiei-Jandaghi NZ, Sadeghi K, Shatizadeh Malekshahi S, Salimi V, Nejati A, et al. First Cases of SARS-CoV-2 in Iran, 2020: Case Series Report. Iran J Public Health. 2020;49(8):1564-8. [PMID] [PMCID] [DOI:10.18502/ijph.v49i8.3903]
  4. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223): 507-13. [DOI:10.1016/S0140-6736(20)30211-7]
  5. Lippi G, Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med. 2020;58(7):1131-4. [DOI:10.1515/cclm-2020-0198] [PMID]
  6. McPherson RA, MR. P. Henry's Clinical Diagnosis and Management by Laboratory Methods. 23 ed. St. Louis, Missouri Elsevier; 2017.
  7. Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, Villamizar-Peña R, Holguin-Rivera Y, Escalera-Antezana JP, et al. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis. 2020;34: 101623. [PMID] [PMCID] [DOI:10.1016/j.tmaid.2020.101623]
  8. Polak SB, Van Gool IC, Cohen D, von der Thüsen JH, van Paassen J. A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression. Mod Pathol. 2020;33(11):2128-38. [PMID] [PMCID] [DOI:10.1038/s41379-020-0603-3]
  9. Blomme S, Smets L, Van Ranst M, Boeckx N, Van Laer C. The influence of COVID-19 on routine hematological parameters of hospitalized patients. Acta Clin Belg. 2020:1-6. [DOI:10.1080/17843286.2020.1814649] [PMID]
  10. Qu R, Ling Y, Zhang YH, Wei LY, Chen X, Li XM, et al. Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19. J Med Virol. 2020;92 (9):1533-41. [DOI:10.1002/jmv.25767] [PMID] [PMCID]
  11. Kazancioglu S, Bastug A, Ozbay BO, Kemirtlek N, Bodur H. The role of haematological parameters in patients with COVID-19 and influenza virus infection. Epidemiol Infect. 2020;148:e272. [PMID] [PMCID] [DOI:10.1017/S095026882000271X]
  12. Anurag A, Jha PK, Kumar A. Differential white blood cell count in the COVID-19: A cross-sectional study of 148 patients. Diabetes Metab Syndr. 2020;14(6):2099-102. [PMID] [PMCID] [DOI:10.1016/j.dsx.2020.10.029]
  13. Yuan X, Huang W, Ye B, Chen C, Huang R, Wu F, et al. Changes of hematological and immunological parameters in COVID-19 patients. Int J Hematol. 2020;112(4):553-9. [DOI:10.1007/s12185-020-02930-w] [PMID] [PMCID]
  14. Westblade LF, Brar G, Pinheiro LC, Paidoussis D, Rajan M, Martin P, et al. SARS-CoV-2 Viral Load Predicts Mortality in Patients with and without Cancer Who Are Hospitalized with COVID-19. Cancer Cell. 2020;38(5):661-71.e2. [DOI:10.1016/j.ccell.2020.09.007] [PMID] [PMCID]
  15. Shi F, Wu T, Zhu X, Ge Y, Zeng X, Chi Y, et al. Association of viral load with serum biomakers among COVID-19 cases. Virology. 2020;546: 122-6. [PMID] [PMCID] [DOI:10.1016/j.virol.2020.04.011]
  16. Hasanoglu I, Korukluoglu G, Asilturk D, Cosgun Y, Kalem AK, Altas AB, et al. Higher viral loads in asymptomatic COVID-19 patients might be the invisible part of the iceberg. Infection. 2020:1-10. [DOI:10.1007/s15010-020-01548-8] [PMID] [PMCID]
  17. World Heath Organization. Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases. Interim guidance; 2020.
  18. Pan F, Ye T, Sun P, Gui S, Liang B, Li L, et al. Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19). Radiology. 2020;295(3): 715-21. [PMID] [PMCID] [DOI:10.1148/radiol.2020200370]
  19. Li X, Liu C, Mao Z, Xiao M, Wang L, Qi S, et al. Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID-19 patients: a systematic review and meta-analysis. Crit Care. 2020;24(1):647. [DOI:10.1186/s13054-020-03374-8] [PMID] [PMCID]
  20. Chan PK, To WK, Ng KC, Lam RK, Ng TK, Chan RC, et al. Laboratory diagnosis of SARS. Emerg Infect Dis. 2004;10(5):825-31. [DOI:10.3201/eid1005.030682] [PMID] [PMCID]
  21. Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395 (10223):514-23. [DOI:10.1016/S0140-6736(20)30154-9]
  22. Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020;25(3). [DOI:10.2807/1560-7917.ES.2020.25.3.2000045]
  23. Favaloro EJ, Lippi G. Recommendations for Minimal Laboratory Testing Panels in Patients with COVID-19: Potential for Prognostic Monitoring. Semin Thromb Hemost. 2020;46(3):379-82. [DOI:10.1055/s-0040-1709498] [PMID] [PMCID]
  24. Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt GM, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003;348(20):1986-94. [DOI:10.1056/NEJMoa030685] [PMID]
  25. Tsang KW, Ho PL, Ooi GC, Yee WK, Wang T, Chan-Yeung M, et al. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003;348(20):1977-85. [DOI:10.1056/NEJMoa030666] [PMID]
  26. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-42. [DOI:10.1001/jama.2020.2648] [PMID]
  27. Lagunas-Rangel FA. Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis. J Med Virol. 2020;92(10):1733-4. [DOI:10.1002/jmv.25819] [PMID] [PMCID]
  28. Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, et al. Hematological findings and complications of COVID-19. Am J Hematol. 2020;95(7):834-47. [DOI:10.1002/ajh.25829] [PMID] [PMCID]
  29. Didangelos A. COVID-19 Hyperinflammation: What about Neutrophils? mSphere. 2020;5(3). [DOI:10.1128/mSphere.00367-20] [PMID] [PMCID]
  30. Venter C, Bezuidenhout JA, Laubscher GJ, Lourens PJ, Steenkamp J, Kell DB, et al. Erythrocyte, Platelet, Serum Ferritin, and P-Selectin Pathophysiology Implicated in Severe Hypercoagulation and Vascular Complications in COVID-19. Int J Mol Sci. 2020;21(21). [DOI:10.3390/ijms21218234] [PMID] [PMCID]
  31. Bahadori M, Dabiri S, Javadi A, Shamsi Meymandi S, Movahedinia S, Shamsi Meymandi M, et al. Pathogenesis of COVID-19; Acute Auto-inflammatory Disease (Endotheliopathica & Leukocytoclastica COVIDicus). Arch Iran Med. 2021;24(5):419-26. [DOI:10.34172/aim.2021.60] [PMID]
  32. Zhao J, Yuan Q, Wang H, Liu W, Liao X, Su Y, et al. Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019. Clin Infect Dis. 2020;71(16):2027-34. [DOI:10.1093/cid/ciaa344] [PMID] [PMCID]
  33. Yip CYC, Yap ES, De Mel S, Teo WZY, Lee CT, Kan S, et al. Temporal changes in immune blood cell parameters in COVID-19 infection and recovery from severe infection. Br J Haematol. 2020;190(1):33-6. [DOI:10.1111/bjh.16847] [PMID] [PMCID]
  34. Yang R, Li X, Liu H, Zhen W, Zhang X, Xiong Q, et al. Chest CT Severity Score: An Imaging Tool for Assessing Severe COVID-19. Radiol Cardiothorac Imaging. 2020;2(2):e200047. [DOI:10.1148/ryct.2020200047] [PMID] [PMCID]
  35. Francone M, Iafrate F, Masci GM, Coco S, Cilia F, Manganaro L, et al. Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis. Eur Radiol. 2020;30(12):6808-17. [DOI:10.1007/s00330-020-07033-y] [PMID] [PMCID]
  36. To KK, Tsang OT, Leung WS, Tam AR, Wu TC, Lung DC, et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis. 2020;20(5):565-74. [DOI:10.1016/S1473-3099(20)30196-1]
  37. Zheng S, Fan J, Yu F, Feng B, Lou B, Zou Q, et al. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study. Bmj. 2020;369: m1443. [DOI:10.1136/bmj.m1443] [PMID] [PMCID]
  38. SARS-CoV-2 variants of concern as of August 5 2021. European Centre for Disease Prevention and Control. [updated 2021-08-14]. Available from: https://www.ecdc.europa.eu/en/covid-19/variants-concern.